ALDH2 and cancer: 2) Because endogenous 4HNE, a typical endogenous aldehyde that accumulates in ALDH2*2 carriers, delays cell proliferation [3, 17–20], ICI resistance due to genetic mutations in cancer cells [21, 22] is less likely to occur.